Pletscher M - Search Results

1

Systematic review of cost-effectiveness modelling studies for haemophilia.

Meier N, Ammann D, Pletscher M, Probst J, Schwenkglenks M. Meier N, et al. Among authors: pletscher m. J Med Econ. 2025 Dec;28(1):89-104. doi: 10.1080/13696998.2024.2444157. Epub 2025 Jan 3. J Med Econ. 2025. PMID: 39693522 Free article. Review.

2

Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany.

Meier N, Fuchs H, Galactionova K, Hermans C, Pletscher M, Schwenkglenks M. Meier N, et al. Among authors: pletscher m. Pharmacoecon Open. 2024 May;8(3):373-387. doi: 10.1007/s41669-024-00480-z. Epub 2024 Mar 23. Pharmacoecon Open. 2024. PMID: 38520664 Free PMC article. Review.

3

How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts.

Wieser S, Riguzzi M, Pletscher M, Huber CA, Telser H, Schwenkglenks M. Wieser S, et al. Among authors: pletscher m. Eur J Health Econ. 2018 Nov;19(8):1149-1161. doi: 10.1007/s10198-018-0963-5. Epub 2018 Feb 22. Eur J Health Econ. 2018. PMID: 29470673 Free article.

4

Burden of seasonal influenza in the Swiss adult population during the 2016/2017-2018/2019 influenza seasons.

Ammann D, Bilger J, Loiacono MM, Oberle SG, Dounas A, Manuel O, Pletscher M. Ammann D, et al. Among authors: pletscher m. Influenza Other Respir Viruses. 2023 Nov;17(11):e13218. doi: 10.1111/irv.13218. Influenza Other Respir Viruses. 2023. PMID: 38019699 Free PMC article.

5

Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland.

Trottmann M, Blozik E, Hilbig M, Pletscher M, Meier N. Trottmann M, et al. Among authors: pletscher m. Swiss Med Wkly. 2024 Oct 3;154:3958. doi: 10.57187/s.3958. Swiss Med Wkly. 2024. PMID: 39465331 Free article.

6

Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Trottmann M, Blozik E, Hilbig M, LoVerdi D, Pedruzzi M, Scherer T, Weiss M, Pletscher M, Meier N. Trottmann M, et al. Among authors: pletscher m. Swiss Med Wkly. 2023 Sep 29;153:3441. doi: 10.57187/s.3441. Swiss Med Wkly. 2023. PMID: 37774383 Free article.

7

Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland.

Pletscher M, Plessow R, Eichler K, Wieser S. Pletscher M, et al. Swiss Med Wkly. 2013 Jan 8;143:w13732. doi: 10.4414/smw.2013.13732. eCollection 2013. Swiss Med Wkly. 2013. PMID: 23300013 Free article.

8

The Societal Costs of Schizophrenia in Switzerland.

Pletscher M, Mattli R, von Wyl A, Reich O, Wieser S. Pletscher M, et al. J Ment Health Policy Econ. 2015 Jun;18(2):93-103. J Ment Health Policy Econ. 2015. PMID: 26231000

9

Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease.

Pletscher M, Walker S, Moschetti K, Pinget C, Wasserfallen JB, Greenwood JP, Schwitter J, Girardin FR. Pletscher M, et al. Eur Heart J Qual Care Clin Outcomes. 2016 Jul 1;2(3):201-207. doi: 10.1093/ehjqcco/qcw008. Eur Heart J Qual Care Clin Outcomes. 2016. PMID: 29474611

10

Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.

Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J. Girardin FR, et al. Among authors: pletscher m. Pharmacogenomics J. 2019 Apr;19(2):211-218. doi: 10.1038/s41397-017-0004-2. Epub 2018 Jan 3. Pharmacogenomics J. 2019. PMID: 29298994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters